H.Res. 1081 is a congressional resolution calling for increased awareness and support for chordoma, a rare but aggressive bone cancer that affects the skull and spine. The disease strikes people of all ages, with approximately 300 new cases diagnosed annually in the United States and more than 25,000 people affected worldwide. Chordoma is particularly difficult to treat because tumors often involve critical brain and spinal structures, and even successful surgery or radiation carries a high recurrence rate, with no known drugs currently available to cure or effectively control the disease. The resolution urges increased funding and support for early diagnosis, development of new treatments and cures, streamlined pathways from research to clinical use, and patient-focused drug development strategies. As a House resolution, this legislation does not allocate specific funding but rather expresses Congress's sense that resources and support for chordoma patients and research should be prioritized.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.